Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of pirfenidone tablets for silicosis-related pulmonary fibrosis
CTR20182268Phase 2Active
- Sponsor
- Zhejiang Jinhua CONBA Bio-Pharm
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in silicosis, pulmonary fibrosis (PF), sponsored by Zhejiang Jinhua CONBA Bio-Pharm. Started May 2019; status: active.
02
Drugs
pirfenidone
03
Conditions
silicosispulmonary fibrosis (PF)
Beyond the preview
Go deeper on CTR20182268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20182268.